Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03510260 · ClinicalTrials.gov registry record · NA
Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial
A NA study of Risk Reduction and Satisfaction, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT03510260 is a NA study of Risk Reduction and Satisfaction that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 105 participants, below the 3,690-participant average among 13 other Risk Reduction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03510260, a NA study of Risk Reduction and Satisfaction, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
· The target population for our study is women who present in their last clinic visit before delivery and are scheduled for an elective cesarean section. In that visit, the provider will notify the research team in order for the subject to be screened for the study. If the subject consents to participation, written informed consent will be obtained by person-to-person contact. The PI, study coordinator, or a collaborator will be responsible for the informed consent. After in-formed consent is obtained, the patient will be randomized to the following study groups: The control group will undergo regular consenting only. Study group I (e-confirmed consent only) will receive an electronic invitation to complete the consent process electronically and will proceed through the Confirmed Consent system prior to arrival to labor and delivery on day of surgery, which is the routine patient flow at this time. After completion of the survey, the subject will sign the regular paper consent for the procedure as standard in our institution. The study group II will undergo the same intervention as group II but the COMRADE survey questionnaire will be obtained by phone or in person after the completion of the paper consent form.
Conditions Studied
Interventions
- OTHER Control Group
- OTHER Study Group I
- OTHER Study Group II
Study Locations (1)
Texas
- UTMB Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2018-05-08 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03510260
The ClinicalTrials.gov registry entry for NCT03510260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,690-participant average among 13 other Risk Reduction trials with a reported enrollment target (97% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Risk Reduction appearing as the primary indexed condition, and to 3 interventions - of which Control Group is the first listed.
NCT03510260 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03510260 about?
NCT03510260 is a clinical study titled "Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial". · The target population for our study is women who present in their last clinic visit before delivery and are scheduled for an elective cesarean section. In that visit, the provider will notify the research team in order for the subject to be screened for the study. If the subject consents to partic...
What is the current status of trial NCT03510260?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2018-05-08. Estimated completion is 2020-08-01.
What conditions does trial NCT03510260 study?
This clinical trial studies the following conditions: Risk Reduction, Satisfaction.
What interventions are being tested in trial NCT03510260?
The interventions under investigation include: Control Group (OTHER), Study Group I (OTHER), Study Group II (OTHER).
Who is sponsoring clinical trial NCT03510260?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03510260 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Risk Reduction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tennessee Youth Prepared for Success
ACTIVE NOT RECRUITING · NA
-
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
COMPLETED · NA
-
Efficacy of Communication Modalities for Promoting Flu Shots
COMPLETED · NA
-
Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness
COMPLETED · NA
-
Building Stronger Allies
COMPLETED · NA
-
Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.